Dr. Bjug Borgundvaag discusses alcohol use disorder and cannabinoid hyperemesis syndrome management in the ED, emphasizing compassionate care, patient involvement in guidelines, evidence-based medicine, and effective management strategies including symptom-driven approaches, adjunctive medications, and novel therapies like capsaicin. The podcast highlights the importance of recognizing these conditions, utilizing evidence-based treatments, and navigating limited evidence in emergency medicine.

Dr. Bjug Borgundvaag, Founding Director of the Schwartz/Reisman Emergency Medicine Institute, dives into critical topics in emergency care. He discusses the GRACE-4 guidelines for managing Alcohol Use Disorder and Cannabinoid Hyperemesis Syndrome, emphasizing evidence-based approaches and reducing stigma. The importance of patient voices in developing clinical guidelines is highlighted to enhance care quality. Additionally, he shares insights on managing alcohol withdrawal, advocating for a compassionate and informed approach to treatment.